SGT-501
/ Solid BioSci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 06, 2025
ARTEMIS: A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Solid Biosciences Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Gene Therapies • Ventricular Tachycardia
1 to 1
Of
1
Go to page
1